Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
TAKEDA PHARMACEUTICAL COMPANY LIMITED	OSAKA-SHI OSAKA 541-0045

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C07F:ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CO....
• C07D:HETEROCYCLIC COMPOUNDS

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Dalgarno, David C	Brookline, US	55	602
Huang, Wei-Sheng	Acton, US	58	567
Shakespeare, William C	Southborough, US	74	1018
Wang, Yihan	Newton, US	122	1020
Zhu, Xiaotian	Newton, US	73	1222

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
7.5 Year Payment	$3600.00	$1800.00	$900.00	Jun 5, 2025
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Jun 5, 2029

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
December 05, 2017	US,9834571,B2   US9834571B2	GRANTED PATENT AS SECOND PUBLICATION
August 25, 2016	US,20160244469,A1   US20160244469A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9834571

Compounds for inhibiting cell proliferation in EGFR-driven cancers

---

 

Legal Events